arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Alpha Cognition Inc.

ACOG
$9.14 ▲ +0.77 (+9.20%) at close
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
17 Visible periods
25 Metrics
Peer-ranked Benchmarks
Price Chart
16
Health
Poor
Bearish
auto_awesome

Analytical Summary

Alpha Cognition Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $198.9M
Dividend Yield
Revenue Growth 20.7%
Op. Margin -229.1%
ROIC -11.1%
FCF / Share $-0.54
Trailing P/E
Price / Book 3.5x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

17-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$3.53M
↑ +20.7%
Net Income Profit after all expenses
$-6.48M
↓ -222.8%
Operating Margin Operating profit as % of sales
-229.1%
↑ +19.3% 0th
FCF / Share Free cash flow per share
$-0.54
↓ -312.1%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
1
Returns
22
Financial Health
2
Cash Quality
66

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 4 years · 17 quarters